Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT03289949
PHASE1

The Neurobiological Effect of 5-HT2AR Modulation

Sponsor: Gitte Moos Knudsen

View on ClinicalTrials.gov

Summary

The investigators wish to investigate neurobiological effects of serotonin 2A receptor modulation in healthy volunteers, contrasting effects of an agonist (psilocybin) and an antagonist (ketanserin). Magnetic resonance imaging (MRI) and positron emission tomography (PET) will be used as neuroimaging tools.

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

200

Start Date

2017-03-03

Completion Date

2030-06-01

Last Updated

2024-12-16

Healthy Volunteers

Yes

Conditions

Interventions

DRUG

Psilocybine

Oral dose of psilocybine.

DRUG

Ketanserin

Oral dose of ketanserin.

Locations (1)

Neurobiology Research Unit, Rigshospitalet

Copenhagen, Denmark